These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23039318)

  • 1. Management of bleeding in patients receiving conventional or new anticoagulants: a practical and case-based approach.
    Donadini MP; Ageno W; Douketis JD
    Drugs; 2012 Oct; 72(15):1965-75. PubMed ID: 23039318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of antithrombotic agents.
    Bauer KA
    Am J Hematol; 2012 May; 87 Suppl 1():S119-26. PubMed ID: 22460529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches to diagnosing and managing anticoagulant-related bleeding.
    Goy J; Crowther M
    Semin Thromb Hemost; 2012 Oct; 38(7):702-10. PubMed ID: 23034830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents.
    Siegal DM
    J Thromb Thrombolysis; 2015 Apr; 39(3):395-402. PubMed ID: 25586208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation Reversal.
    Simon EM; Streitz MJ; Sessions DJ; Kaide CG
    Emerg Med Clin North Am; 2018 Aug; 36(3):585-601. PubMed ID: 30037445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of specific antidotes as a response to bleeding complications during anticoagulant therapy for venous thromboembolism.
    Haverkamp D; Hutten BA; Büller HR; Gallus AS; Lensing AW; Prins MH
    J Thromb Haemost; 2003 Jan; 1(1):69-73. PubMed ID: 12871541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Direct oral anticoagulant associated bleeding].
    Godier A; Martin AC; Rosencher N; Susen S
    J Mal Vasc; 2016 Jul; 41(4):272-8. PubMed ID: 27297642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How we treat bleeding associated with direct oral anticoagulants.
    Marano G; Vaglio S; Pupella S; Liumbruno GM; Franchini M
    Blood Transfus; 2016 Sep; 14(5):465-73. PubMed ID: 27136433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bleeding complications of anticoagulant therapy].
    Gumulec J; Kessler P; Procházka V; Brejcha M; Penka M; Zänger M; Machytka E; Klement P
    Vnitr Lek; 2009 Mar; 55(3):277-89. PubMed ID: 19378860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific antidotes in development for reversal of novel anticoagulants: a review.
    Gomez-Outes A; Suarez-Gea ML; Lecumberri R; Terleira-Fernandez AI; Vargas-Castrillon E
    Recent Pat Cardiovasc Drug Discov; 2014; 9(1):2-10. PubMed ID: 25494843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct oral anticoagulants: new drugs and new concepts.
    Levy JH; Spyropoulos AC; Samama CM; Douketis J
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1333-51. PubMed ID: 25523529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding and antidotes in new oral anticoagulants.
    Majeed A; Schulman S
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):191-202. PubMed ID: 23953907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of novel oral anticoagulants in patients with major bleeding.
    Siegal DM; Cuker A
    J Thromb Thrombolysis; 2013 Apr; 35(3):391-8. PubMed ID: 23389753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.
    Linkins LA; Choi PT; Douketis JD
    Ann Intern Med; 2003 Dec; 139(11):893-900. PubMed ID: 14644891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency management of bleeding associated with old and new oral anticoagulants.
    Peacock WF; Gearhart MM; Mills RM
    Clin Cardiol; 2012 Dec; 35(12):730-7. PubMed ID: 22811404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing a management plan for oral anticoagulant reversal.
    Dager WE
    Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S21-31. PubMed ID: 23640529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of Dabigatran with Idarucizumab.
    Sodha NR; Sellke FW
    Expert Rev Cardiovasc Ther; 2016 Aug; 14(8):889-93. PubMed ID: 27362456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Severe Bleeding in Patients Treated With Oral Anticoagulants: Proceedings Monograph From the Emergency Medicine Cardiac Research and Education Group-International Multidisciplinary Severe Bleeding Consensus Panel October 20, 2018.
    Gibler WB; Racadio JM; Hirsch AL; Roat TW
    Crit Pathw Cardiol; 2019 Sep; 18(3):143-166. PubMed ID: 31348075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of direct oral anticoagulant therapy reversal.
    Gulseth MP
    Am J Health Syst Pharm; 2016 May; 73(10 Suppl 2):S5-S13. PubMed ID: 27147458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
    Beyer-Westendorf J; Ageno W
    Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.